Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Salvigenin
Cat. No.:
OB0225LY-0375
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Salvigenin is a plant-derived compound with antioxidant and anti-inflammatory properties.
Synonym:
19103-54-9; 5-Hydroxy-6,7,4'-trimethoxyflavone; 7-O-Methylpectolinarigenin; 4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-; 5-Hydroxy-4',6,7-trimethoxyflavone
CAS No.:
19103-54-9
Compound CID:
161271
Formula:
C18H16O6
Formula Weight:
328.32
Specification
Relative Density:
1.314 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Salvigenin can be used as a potent hMAO-A inhibitor.
Library Information
Targets:
MAOs; Protein kinases/enzymes
Receptors:
hMAO-A; ROS Kinase
Pathways:
Neuronal signaling; Autophagy; Metabolism; Tyrosine kinase/adaptors
Plate Number:
AOCL-5
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
4.4 mg/mL; 13.4 mM
